Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||
| Earning before tax | 36.58%1.61B | 36.65%898.6M | 32.54%1.18B | 41.05%657.61M | 90.13%887.86M | --466.24M | 5.20%466.99M | --443.89M |
| Profit adjustment | ||||||||
| Interest (income) - adjustment | -421.57%-75.12M | -327.91%-27.46M | 27.19%-14.4M | 31.96%-6.42M | -44.60%-19.78M | ---9.43M | -100.88%-13.68M | ---6.81M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | 59.38%-351K | ---864K |
| Attributable subsidiary (profit) loss | -131.53%-11.62M | -758.50%-4.59M | -814.08%-5.02M | ---535K | --703K | ---- | ---- | ---- |
| Impairment and provisions: | 117.26%698K | 77.83%-303K | -774.96%-4.04M | -398.47%-1.37M | -80.30%599K | --458K | -48.17%3.04M | --5.87M |
| -Impairmen of inventory (reversal) | 164.88%399K | -123.74%-1.38M | -138.51%-615K | -171.26%-615K | -26.30%1.6M | --863K | -22.47%2.17M | --2.8M |
| -Impairment of trade receivables (reversal) | 108.72%299K | 242.69%1.07M | -243.49%-3.43M | -85.68%-752K | -214.32%-998K | ---405K | -71.56%873K | --3.07M |
| Revaluation surplus: | ---5.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Derivative financial instruments fair value (increase) | ---5.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | 145.87%111K | ---- | -952.17%-242K | -2,520.00%-242K | -155.56%-23K | --10K | 93.08%-9K | ---130K |
| -Loss (gain) on sale of property, machinery and equipment | 145.87%111K | ---- | -952.17%-242K | -2,520.00%-242K | -155.56%-23K | --10K | 93.08%-9K | ---130K |
| Depreciation and amortization: | 15.73%90.85M | 12.59%42.01M | 11.88%78.5M | 6.97%37.31M | 5.45%70.16M | --34.88M | 10.16%66.53M | --60.4M |
| -Amortization of intangible assets | 3.59%865K | -12.85%400K | 16.46%835K | 55.59%459K | 120.62%717K | --295K | 28.46%325K | --253K |
| Financial expense | -56.10%2.32M | -60.02%1.02M | 160.16%5.29M | 126.24%2.56M | -34.74%2.03M | --1.13M | 11.05%3.12M | --2.81M |
| Exchange Loss (gain) | 2,130.91%43.83M | --24.16M | ---2.16M | ---- | ---- | ---- | ---- | ---- |
| Special items | -75.02%3.62M | -65.48%1.6M | 3,166.95%14.48M | 4,140.00%4.65M | 92.19%-472K | ---115K | ---6.04M | ---- |
| Operating profit before the change of operating capital | 32.63%1.66B | 34.82%935.05M | 32.73%1.25B | 40.63%693.57M | 81.12%941.09M | --493.17M | 2.86%519.6M | --505.15M |
| Change of operating capital | ||||||||
| Inventory (increase) decrease | -1,125.13%-195.26M | -305.17%-62.06M | 142.97%19.05M | 729.45%30.25M | 51.76%-44.33M | --3.65M | 2.97%-91.9M | ---94.72M |
| Accounts receivable (increase)decrease | 53.12%-26.25M | -0.73%-77.2M | -25.47%-55.99M | 13.71%-76.64M | -1,423.56%-44.63M | ---88.82M | 88.91%-2.93M | ---26.4M |
| Accounts payable increase (decrease) | 45.42%117.11M | 65.30%216.84M | 49.99%80.53M | 212.86%131.18M | -49.00%53.69M | --41.93M | 707.37%105.27M | --13.04M |
| prepayments (increase)decrease | -461.01%-16.72M | -31.65%-13.43M | 88.25%-2.98M | 47.72%-10.2M | -1,287.31%-25.36M | ---19.51M | 62.95%-1.83M | ---4.93M |
| Special items for working capital changes | 201.53%47.92M | 5,990.60%47.93M | -3,001.25%-47.2M | --787K | -12,783.33%-1.52M | ---- | 100.95%12K | ---1.26M |
| Cash from business operations | 27.44%1.58B | 36.18%1.05B | 41.37%1.24B | 78.65%768.94M | 66.40%878.94M | --430.41M | 35.14%528.22M | --390.87M |
| Other taxs | -40.21%-384.12M | -44.48%-216.53M | -52.85%-273.96M | -77.74%-149.87M | -27.93%-179.23M | ---84.32M | -54.07%-140.11M | ---90.94M |
| Net cash from operations | 23.83%1.2B | 34.17%830.59M | 38.43%968.6M | 78.87%619.07M | 80.28%699.71M | --346.09M | 29.40%388.12M | --299.93M |
| Cash flow from investment activities | ||||||||
| Interest received - investment | 620.58%69.64M | 401.75%32.19M | -51.14%9.67M | -31.96%6.42M | 44.60%19.78M | --9.43M | 100.88%13.68M | --6.81M |
| Loan receivable (increase) decrease | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---990.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | -80.08%105K | -84.85%55K | 147.42%527K | --363K | 85.22%213K | ---- | -69.66%115K | --379K |
| Purchase of fixed assets | -51.80%-186.16M | -105.24%-114.09M | -69.87%-122.63M | -103.19%-55.59M | -117.81%-72.19M | ---27.36M | 19.27%-33.15M | ---41.06M |
| Purchase of intangible assets | 99.83%-844K | 99.93%-121K | -3,431.96%-493.27M | -9,340.68%-178.24M | -989.39%-13.97M | ---1.89M | -161.63%-1.28M | ---490K |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | --63.1M | ---- |
| Cash on investment | ---- | ---- | 82.70%-22.24M | ---22.24M | -962.31%-128.54M | ---- | 76.27%-12.1M | ---51M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | -38.31%533K | --864K |
| Net cash from investment operations | -76.48%-1.11B | 67.12%-81.97M | -222.51%-627.95M | -1,158.01%-249.29M | -730.14%-194.71M | ---19.82M | 136.57%30.9M | ---84.5M |
| Net cash before financing | -73.23%91.2M | 102.45%748.62M | -32.55%340.64M | 13.33%369.78M | 20.52%505M | --326.28M | 94.50%419.02M | --215.44M |
| Cash flow from financing activities | ||||||||
| New borrowing | ---- | ---- | --416.94M | --98.63M | ---- | ---- | --1.73M | ---- |
| Refund | -219.63%-319.63M | ---320M | ---100M | ---- | ---- | ---- | ---- | ---- |
| Issuing shares | -84.98%311.11M | --311.11M | --2.07B | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | -4.13%-2.32M | 13.88%-1.02M | -9.69%-2.23M | -5.04%-1.19M | 34.74%-2.03M | ---1.13M | -11.05%-3.12M | ---2.81M |
| Dividends paid - financing | 65.57%-352.94M | 65.57%-352.94M | -355.56%-1.03B | -355.56%-1.03B | ---225M | ---225M | ---- | ---40M |
| Absorb investment income | ---- | ---- | --96M | ---- | ---- | ---- | ---- | --355K |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---10.65M | ---7.58M | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---96.7M | ---700K | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -130.90%-405.12M | 60.13%-380.64M | 614.11%1.31B | -296.26%-954.78M | -1,023.77%-255.01M | ---240.95M | 65.39%-22.69M | ---65.56M |
| Effect of rate | -1,968.63%-40.33M | ---24.16M | --2.16M | ---- | ---- | ---- | ---- | ---- |
| Net Cash | -119.01%-313.92M | 162.90%367.98M | 560.68%1.65B | -785.58%-584.99M | -36.92%250M | --85.33M | 164.44%396.32M | --149.88M |
| Begining period cash | 145.34%2.79B | 145.34%2.79B | 28.16%1.14B | 28.16%1.14B | 80.62%887.9M | --887.9M | 43.86%491.58M | --341.7M |
| Cash at the end | -12.69%2.44B | 467.11%3.14B | 145.34%2.79B | -43.19%552.9M | 28.16%1.14B | --973.23M | 80.62%887.9M | --491.58M |
| Cash balance analysis | ||||||||
| Cash and bank balance | ---- | 465.26%3.14B | ---- | --555.09M | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.